Alpine Immune Sciences logo

Alpine Immune Sciences

Seattle, WA

Alpine Immune Sciences, Inc. (AIS) focuses on developing novel protein-based cancer immunotherapies using its proprietary variant ig domain (vIgD) platform technology. The Company develops TIP technology, based on the vIgD platform, to enhance engineered cellular therapies. AIS offers a platform to interact with multiple targets, including many present in the immune synapse.

alpineimmunesciences.com

Company Details

Founded

2015

Employees

Between 100 - 500 employees

Raised

$515,300,000

Headquarters Location

Seattle, WA

Public

Yes

Acquired

Yes

CEO

Mitchell GoldMitchell Gold

Founders

Michael Kornacker
Michael Kornacker
Mitchell Gold
Mitchell Gold
Ryan Swanson
Ryan Swanson

Company Collections

These are collections Alpine Immune Sciences is a part of. Click on the collection name to view similar companies.

Alpine Immune Sciences' Industries

Alpine Immune Sciences' Tech Stack

Alpine Immune Sciences' Investors